Professional
Added to YB: 2024-07-30
Pitch date: 2024-06-30
BSX [bullish]
Boston Scientific Corporation
-42.3%
current return
Author Info
No bio for this author
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$63.4B
Pitch Price
$77.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
13.32
P/E
17.86
EV/Sales
3.55
Sector
Health Care Equipment and Supplies
Category
growth
Aristotle Core Equity New Position: Boston Scientific Corporation
BSX: Med device leader w/ 8-10% organic growth, 150bps op margin expansion, & category leadership targeted 2024-26. Strong post-COVID utilization, aging demographics, innovation driving market share. 60% US rev, 130 countries. Consistent organic growth acceleration & accretive M&A track record. Cardiovascular, rhythm mgmt, neuromod, uro/pelvic health products.
Read full article (1 min)